{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T20:48:07Z","timestamp":1770497287553,"version":"3.49.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T00:00:00Z","timestamp":1694563200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018551","name":"Jones Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018551","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.ekir.2023.09.013","type":"journal-article","created":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T11:35:44Z","timestamp":1694950544000},"page":"2646-2653","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Association Between Serum Vancomycin Level and Clinical Outcome in Patients With Peritoneal Dialysis Associated Peritonitis"],"prefix":"10.1016","volume":"8","author":[{"given":"Erin","family":"Deacon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Canney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brendan","family":"McCormick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Ramsay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohan","family":"Biyani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre Antoine","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Zimmerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2023.09.013_bib1","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1681\/ASN.2011121135","article-title":"Recent peritonitis associates with mortality among patients treated with peritoneal dialysis","volume":"23","author":"Boudville","year":"2012","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2023.09.013_bib2","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/089686080902900314","article-title":"Peritonitis remains the major clinical complication of peritoneal dialysis: the London, UK, peritonitis audit 2002-2003","volume":"29","author":"Davenport","year":"2009","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.ekir.2023.09.013_bib3","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1093\/oxfordjournals.ndt.a027318","article-title":"Longitudinal changes in peritoneal kinetics: the effects of peritoneal dialysis and peritonitis","volume":"11","author":"Davies","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2023.09.013_bib4","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3747\/pdi.2010.00185","article-title":"Peritoneal dialysis-associated peritonitis rates and outcomes in a national cohort are not improving in the post-millennium (2000-2007)","volume":"31","author":"Brown","year":"2011","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.ekir.2023.09.013_bib5","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1177\/08968608221080586","article-title":"ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment","volume":"42","author":"Li","year":"2022","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.ekir.2023.09.013_bib6","first-page":"154","article-title":"Vancomycin: the tale of the vanquisher and the pyrrhic victory","volume":"34","author":"De Vriese","year":"2014","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.ekir.2023.09.013_bib7","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3747\/pdi.2010.00294","article-title":"Intraperitoneal vancomycin concentrations during peritoneal dialysis-associated peritonitis: correlation with serum levels","volume":"32","author":"Fish","year":"2012","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.ekir.2023.09.013_bib8","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.2215\/CJN.00630117","article-title":"Residual kidney function and peritoneal dialysis-associated peritonitis treatment outcomes","volume":"12","author":"Whitty","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2023.09.013_bib9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/08968608211064192","article-title":"Serum vancomycin levels predict the short-term adverse outcomes of peritoneal dialysis-associated peritonitis","volume":"43","author":"Ma","year":"2023","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.ekir.2023.09.013_bib10","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1177\/08968608211051579","article-title":"Evaluation of intraperitoneal vancomycin in peritoneal dialysis-associated peritonitis","volume":"42","author":"Chang","year":"2022","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.ekir.2023.09.013_bib11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/08968608221134980","article-title":"Predictors of serum vancomycin levels in peritoneal dialysis-associated peritonitis","volume":"43","author":"Deacon","year":"2023","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.ekir.2023.09.013_bib12","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3747\/pdi.2016.00078","article-title":"ISPD peritonitis recommendations: 2016 update on prevention and treatment","volume":"36","author":"Li","year":"2016","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.ekir.2023.09.013_bib14","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/0272-6386(95)90132-9","article-title":"Trough serum vancomycin levels predict the relapse of gram-positive peritonitis in peritoneal dialysis patients","volume":"25","author":"Mulhern","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2023.09.013_bib15","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3747\/pdi.2013.00156","article-title":"The role of monitoring vancomycin levels in patients with peritoneal dialysis-associated peritonitis","volume":"35","author":"Stevenson","year":"2015","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.ekir.2023.09.013_bib16","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1093\/ndt\/gfm079","article-title":"Single UK centre experience on the treatment of PD peritonitis--antibiotic levels and outcomes","volume":"22","author":"Blunden","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2023.09.013_bib17","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1093\/ndt\/gfm242","article-title":"Reduced residual renal function is a risk of peritonitis in continuous ambulatory peritoneal dialysis patients","volume":"22","author":"Han","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2023.09.013_bib18","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1177\/089686080502500311","article-title":"Peritonitis-related mortality in patients undergoing chronic peritoneal dialysis","volume":"25","author":"Font\u00e1n","year":"2005","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.ekir.2023.09.013_bib19","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1053\/j.ajkd.2017.09.010","article-title":"Impact of obesity on modality longevity, residual kidney function, peritonitis, and survival among incident peritoneal dialysis patients","volume":"71","author":"Obi","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2023.09.013_bib20","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nrneph.2013.99","article-title":"Peritoneal changes in patients on long-term peritoneal dialysis","volume":"9","author":"Krediet","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ekir.2023.09.013_bib21","doi-asserted-by":"crossref","first-page":"e489","DOI":"10.1016\/j.ijid.2009.07.016","article-title":"Peritoneal dialysis-associated peritonitis: clinical features and predictors of outcome","volume":"14","author":"Kofteridis","year":"2010","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ekir.2023.09.013_bib22","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1177\/089686080202200508","article-title":"Predictors of Outcome following Bacterial Peritonitis in peritoneal dialysis","volume":"22","author":"Krishnan","year":"2002","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.ekir.2023.09.013_bib23","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/00007691-199410000-00013","article-title":"Vancomycin pharmacokinetics in a patient population: effect of age, gender, and body weight","volume":"16","author":"Ducharme","year":"1994","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.ekir.2023.09.013_bib24","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1177\/0897190014546114","article-title":"Vancomycin nephrotoxicity: a review","volume":"27","author":"Mergenhagen","year":"2014","journal-title":"J\u00a0Pharm Pract"},{"key":"10.1016\/j.ekir.2023.09.013_bib25","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1177\/0896860819889774","article-title":"Vancomycin in peritoneal dialysis: clinical pharmacology considerations in therapy","volume":"40","author":"Lam","year":"2020","journal-title":"Perit Dial Int"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024923015061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024923015061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T03:45:44Z","timestamp":1762832744000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024923015061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S2468024923015061"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2023.09.013","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Association Between Serum Vancomycin Level and Clinical Outcome in Patients With Peritoneal Dialysis Associated Peritonitis","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2023.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}